(AGENPARL) – WASHINGTON lun 01 maggio 2023 CHICAGO – Health plan participants, employers and medical providers harmed by a multiple…
Browsing: approves
(AGENPARL) – SILVER SPRING lun 01 maggio 2023 FDA conditionally approved Varenzin-CA1 (molidustat oral suspension) the first drug for the control…
(AGENPARL) – RADFORD (VIRGINIA) sab 29 aprile 2023 In a special meeting held on April 28, the Radford University Board of Visitors…
(AGENPARL) – NEW YORK ven 28 aprile 2023 Closing its twenty-second session this afternoon, the Permanent Forum on Indigenous Issues…
(AGENPARL) – SILVER SPRING mer 26 aprile 2023 FDA approves Vowst, the first orally administered fecal microbiota product. Vowst is approved…
(AGENPARL) – BRUXELLES mar 25 aprile 2023 The Council has approved conclusions on the opportunities of a sustainable and circular…
(AGENPARL) – SILVER SPRING mar 25 aprile 2023 FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS) associated…
(AGENPARL) – NEW YORK lun 24 aprile 2023 After three weeks of discussions, the Disarmament Commission concluded its 2023 substantive…
(AGENPARL) – lun 24 aprile 2023 FOR IMMEDIATE RELEASE NOVATEK’s AGM Approves Dividends Moscow, April PAO NOVATEK (“NOVATEK” and/or the…
(AGENPARL) – WASHINGTON mar 18 aprile 2023 Action makes more Medicaid funding available for school-based health services in Illinois, improving…